“Gas station heroin” tianeptine alarms doctors as Connecticut joins 14 states in ban
Tianeptine, sold illicitly in the U.S. as a “dietary supplement” and nicknamed “gas station heroin,” produces opioid-like effects, causing addiction, overdoses, and deaths — prompting Connecticut and other states to move toward bans and tighter regulation.
- Connecticut recently moved to ban the sale and use of tianeptine, joining at least 14 states that have scheduled or restricted the drug.
- Tianeptine is unapproved in the U.S.; at high doses it stimulates mu‑opioid receptors and can be more potent than morphine, producing euphoria, addiction and life‑threatening respiratory depression.
- Products are sold as pills, powders, salts and liquids at convenience stores, gas stations, vape shops and online under brand names like Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red.
- Public health agencies and clinicians warn that marketed “supplements” are deceptive and dangerous; poison centers report rising severe cases and clusters linked to specific products.
What is tianeptine and why regulators are acting
Tianeptine is a tricyclic antidepressant legally prescribed in parts of Europe, Asia and South America at low, therapeutic doses. In the U.S., the U.S. Food and Drug Administration has never approved tianeptine for medical use or as a dietary supplement. Misuse in the U.S. often involves doses far above therapeutic levels (reports range from roughly 50 mg to 10,000 mg daily), taken to self‑treat pain, anxiety or withdrawal, or for recreation.
Because many standard drug screens do not detect tianeptine, sellers have marketed it as a seemingly benign supplement with candy‑like flavors and attractive claims, increasing its spread in small retail outlets and online.
State and federal responses
Faced with rising poisonings, heavy dependence and clusters of severe outcomes, states have acted. Connecticut added tianeptine (along with kratom and other substances) to its controlled list after officials cited deceptive marketing and youth exposure concerns. At least 14 states now list tianeptine as a Schedule I substance (state lists vary).
Congressional lawmakers have reintroduced legislation to curb marketing of tianeptine products; FDA and public‑health experts continue to issue warnings that risks outweigh any perceived benefits for depression or anxiety. See the Pallone/Durbin press release for federal legislative action.
How tianeptine harms people: medical evidence and cases
Tianeptine’s danger stems from two pharmacologic effects: at low doses it affects serotonin pathways; at higher doses it binds mu‑opioid receptors and acts like strong opioids, suppressing breathing and risking coma or death (NCBI summaries; FDA).
Reported effects from misuse include agitation, confusion, severe drowsiness, slowed or stopped breathing, seizures, vomiting, hypotension and death. Mixing tianeptine with alcohol, benzodiazepines, other opioids or certain synthetic additives has produced particularly severe outcomes — notably a New Jersey cluster tied to a product sold as Neptune’s Fix (New Jersey DOH health alert).
Poison centers report increasing calls involving tianeptine; in Virginia about one‑third of recent cases required intensive care. New Jersey’s 2024 cluster included deaths and prolonged cardiac rhythm problems associated with contaminated or altered product formulations (VCU Health summary).
Withdrawal and addiction risk
Withdrawal from regular tianeptine misuse resembles opioid withdrawal: intense cravings, sweating, diarrhea, chills, muscle aches and anxiety. Clinicians warn that people with prior substance‑use disorder face higher risk of dependence and dangerous patterns of use (Mayo Clinic overview).
Experts weighing in
“Increasing doses may become lethal” because mu‑opioid receptor stimulation can cause loss of respiratory drive and cardiac arrest — Dr. Robert Schwaner, vice chair, Stony Brook Emergency Medicine.
Emergency physicians and addiction specialists urge national action. The FDA advises parents and clinicians to be alert to tianeptine dangers and the risk to youth.
Marketing, availability and where consumers find it
Tianeptine products appear in small retail outlets and online. They are sold as pills, powders, salts or liquids and often labeled as mood enhancers, pain relievers or mental‑alertness aids despite no U.S. approval. Common brand names include Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red (FDA).
Public health advice and resources
Officials urge anyone who suspects exposure to call Poison Control immediately: 1-800-222-1222. For substance‑use help, the Substance Abuse and Mental Health Services Administration provides a 24/7 national helpline and resources (SAMHSA national helpline).
Clinicians recommend licensed, approved treatments for depression, anxiety or pain and warn against unregulated products marketed as supplements (Mayo Clinic).
Implications for Paso Robles, California
Economic: Paso Robles’ wine and tourism economy includes many convenience stores and gas stations. Sales of unregulated products like tianeptine expose retailers to legal and reputational risk if enforcement tightens — retailers should audit inventory and remove suspicious products to avoid fines or liability.
Political: State bans and federal regulation may find local support; leaders and law enforcement could face pressure to coordinate enforcement and monitor emerging substances.
Social & Cultural: Small communities feel substance‑misuse harms quickly. Families, schools and faith groups should be alerted to flavored, candy‑like products and taught to report suspicious sales. Messaging that emphasizes child safety, community standards and neighborly support will resonate locally.
Practical applications for residents
- Retailers: Inspect supplies, remove products labeled as tianeptine or bearing brands such as Tianaa, ZaZa, Neptune’s Fix, and require invoices from reputable suppliers (FDA guidance).
- Parents & Schools: Be aware tianeptine products can look like candy or flavored supplements; report suspected sales to local law enforcement.
- Health providers: Train emergency and primary care staff to recognize tianeptine toxicity and to consult poison control and public‑health alerts (NJ health alert).
- Individuals seeking help: Contact Poison Control at 1-800-222-1222 or SAMHSA’s helpline for treatment referrals.
Sources and further reading
- U.S. Food and Drug Administration: “New ‘gas station heroin’ tianeptine product trend”
- National Center for Biotechnology Information: Research summaries on tianeptine
- VCU Health: “What you need to know about gas station heroin”
- Mayo Clinic: Tianeptine safety overview
- New Jersey Department of Health: Health alert on tianeptine cluster (Neptune’s Fix)
- House Energy & Commerce Committee press release on Pallone/Durbin bill
- Talbot Health: Emerging substances overview
- SAMHSA national helpline information
